TY  - GEN
AU  - Little,Annette S
AU  - Balmanno,Kathryn
AU  - Sale,Matthew J
AU  - Newman,Scott
AU  - Dry,Jonathan R
AU  - Hampson,Mark
AU  - Edwards,Paul A W
AU  - Smith,Paul D
AU  - Cook,Simon J
TI  - A correction to the research article titled: "Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells" by A. S. Little, K. Balmanno, M. J. Sale, S. Newman, J. R. Dry, M. Hampson, P. A. W. Edwards, P. D. Smith, S. J. Cook
SN  - 1937-9145
PY  - 2011///0824
KW  - Benzimidazoles
KW  - Cell Cycle
KW  - drug effects
KW  - Cell Death
KW  - Cell Line, Tumor
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - Drug Resistance, Neoplasm
KW  - genetics
KW  - Gene Amplification
KW  - Genes, ras
KW  - Humans
KW  - MAP Kinase Signaling System
KW  - Mitogen-Activated Protein Kinase Kinases
KW  - antagonists & inhibitors
KW  - Phosphoinositide-3 Kinase Inhibitors
KW  - Proto-Oncogene Proteins
KW  - Proto-Oncogene Proteins B-raf
KW  - Proto-Oncogene Proteins p21(ras)
KW  - Up-Regulation
KW  - ras Proteins
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Corrected and Republished Article
UR  - https://doi.org/10.1126/scisignal.4170er2
ER  -